PRS9 THE COST-EFFECTIVENESS OF TARGETED PRESCRIBING OF ANTIMICROBIALS IN CANADA FOR COMMUNITY-ACQUIRED PNEUMONIA IN AN ERA OF ANTIMICROBIAL RESISTANCE
May 1, 2008, 00:00
10.1016/S1098-3015(10)70857-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70857-3/fulltext
Title :
PRS9 THE COST-EFFECTIVENESS OF TARGETED PRESCRIBING OF ANTIMICROBIALS IN CANADA FOR COMMUNITY-ACQUIRED PNEUMONIA IN AN ERA OF ANTIMICROBIAL RESISTANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70857-3&doi=10.1016/S1098-3015(10)70857-3
First page :
Section Title :
Open access? :
No
Section Order :
612